ATLASCullinan Therapeutics (CGEM) earnings date: Nov 5, 2026
Cullinan Therapeutics (CGEM) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026. Analysts expect EPS of -$0.79.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CGEM
| Last price | $14.92 (-0.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.1% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Cullinan Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Cullinan Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Cullinan Therapeutics. You can switch it off at any time.
Alert me before CGEM reportsFree to start. Creating an account takes under a minute.
Notify me when Cullinan Therapeutics reports
Track CGEM free Add Cullinan Therapeutics to a free ATLAS watchlist and see its next report date in one place.
CGEM earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.79 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +15.6% |
| Average move around a report | ±5.5% (last 5) |
| Sector | Healthcare · Biotechnology |
Cullinan Therapeutics earnings history: last 5 reports
Cullinan Therapeutics last reported on Aug 6, 2026: EPS of -$0.81 against an estimate of -$0.85 (+4.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.85 | -$0.81 | +4.7% | Beat | +0.7% |
| May 26, 2026 | -$0.08 | -$0.05 | +37.5% | Beat | +12.1% |
| May 7, 2026 | -$0.84 | -$0.75 | +10.7% | Beat | -2.9% |
| Mar 10, 2026 | -$0.84 | -$0.77 | +8.3% | Beat | -6.5% |
| Feb 27, 2026 | $0.18 | $0.21 | +16.7% | Beat | +5.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CGEM
See the fair value, the probability range and the earnings history of Cullinan Therapeutics on its ATLAS page.
Cullinan Therapeutics (CGEM) stock analysisPlans from €3.99 a month.
Cullinan Therapeutics earnings: frequently asked questions
When does Cullinan Therapeutics (CGEM) report earnings?
Cullinan Therapeutics is scheduled to report on Thursday, November 5, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CGEM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.79 per share (USD). Estimates can change before the report.
How often does CGEM beat earnings estimates?
Of its last 5 reports with a recorded result, Cullinan Therapeutics beat the EPS estimate 5 times; the average surprise was +15.6%. Past results do not predict the next one.
How much does CGEM move around earnings?
Over its last 5 reports the stock moved an average of 5.5% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Cullinan Therapeutics beat earnings estimates last quarter?
Cullinan Therapeutics last reported on Aug 6, 2026: EPS of -$0.81 against an estimate of -$0.85 (+4.7% surprise), a beat.
How much does CGEM usually move in a day?
On a normal trading day the ATLAS model puts CGEM’s one-day range at about ±4.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer